TG
AGN

TCW Group’s Allergan plc AGN Stock Holding History

TCW Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-130,569
Closed -$22M – 310
2019
Q3 		$22M Sell
130,569
-107,656
-45% -$17.5M 0.25% 89
2019
Q2 		$39.9M Sell
238,225
-37,842
-14% -$5.24M 0.42% 71
2019
Q1 		$40.4M Buy
276,067
+76,739
+38% +$11.1M 0.39% 76
2018
Q4 		$26.6M Buy
199,328
+88,326
+80% +$14.5M 0.28% 92
2018
Q3 		$21.1M Buy
+111,002
New +$20.4M 0.17% 110
2018
Q2 		– Sell
-12,243
Closed -$2.06M – 378
2018
Q1 		$2.06M Sell
12,243
-287,834
-96% -$48.3M 0.02% 218
2017
Q4 		$49.1M Sell
300,077
-113,495
-27% -$20.4M 0.4% 76
2017
Q3 		$84.8M Sell
413,572
-530
-0.1% -$123K 0.67% 58
2017
Q2 		$101M Sell
414,102
-15,855
-4% -$3.73M 0.84% 46
2017
Q1 		$103M Sell
429,957
-315,689
-42% -$73.5M 0.86% 48
2016
Q4 		$157M Sell
745,646
-24,122
-3% -$5M 1.18% 24
2016
Q3 		$177M Buy
769,768
+50,439
+7% +$12.3M 1.35% 21
2016
Q2 		$166M Buy
719,329
+173,916
+32% +$40.1M 1.26% 23
2016
Q1 		$146M Sell
545,413
-21,855
-4% -$6.26M 1.07% 31
2015
Q4 		$177M Buy
567,268
+21,346
+4% +$6.36M 1.27% 24
2015
Q3 		$148M Buy
545,922
+14,553
+3% +$4.47M 1.06% 33
2015
Q2 		$161M Sell
531,369
-98,039
-16% -$29.2M 1.04% 29
2015
Q1 		$187M Buy
629,408
+555,208
+748% +$158M 0.9% 32
2014
Q4 		$19.1M Sell
74,200
-55,250
-43% -$13.8M 0.08% 169
2014
Q3 		$31.2M Buy
129,450
+42,050
+48% +$9.41M 0.13% 152
2014
Q2 		$19.5M Buy
87,400
+800
+0.9% +$166K 0.08% 212
2014
Q1 		$17.8M Buy
86,600
+600
+0.7% +$119K 0.07% 210
2013
Q4 		$14.4M Buy
86,000
+6,050
+8% +$946K 0.06% 256
2013
Q3 		$11.5M Buy
79,950
+17,350
+28% +$2.31M 0.05% 287
2013
Q2 		$7.9M Buy
+62,600
New +$7.09M 0.04% 356

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TCW Group's AGN Position: Q4 2019 in Review

TCW Group sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 130,569 shares — an estimated $22M sold.

TCW Group first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $187M in Q1 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • TCW Group reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • TCW Group sold 130,569 Allergan plc shares in Q4 2019, an estimated $22M.
  • TCW Group first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • TCW Group's Allergan plc position peaked at $187M in Q1 2015.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on TCW Group's 13F filing for Q4 2019, filed 10 Feb 2020.